Drug Trial Radar · NCT06707090
Tissue Repair Gel in Venous Leg Ulcers (US)
Last checked: Nov 20, 2026Latest source record: Feb 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
312
Planned (sponsor's estimate)
Start
Jan 28, 2025
Primary completion
Dec 2027
Study completion Feb 2028
Sponsor
- Lead sponsor
- TR TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Conditions
- Venous Leg Ulcer
- Venous Ulcer
- Venous Stasis Ulcer
- Venous Stasis
- Wound Heal
- Wounds
- Venous Insufficiency of Leg
- Non-healing Wound
Interventions
TR987 0.1% gel + Standard of CareDrug
6mg topical gel for application plus Standard of Care (wound cleansing/dressings and compression bandaging)
Standard of careOther
Standard of Care (wound cleansing/dressings and compression bandaging)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with Complete Closure of the target ulcer at or before the Week-16 end of treatment (EOT) visit.Time frame: 16 weeks
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Clincial Research Site 21
Tucson, Arizona · Active not recruiting
Clincial Research Site 43C
Castro Valley, California · Recruiting
Clincial Research Site 14
Fresno, California · Recruiting
Clincial Research Site 11
Los Angeles, California · Recruiting
Clincial Research Site 43A
San Francisco, California · Recruiting
Clincial Research Site 43B
San Francisco, California · Recruiting
Clincial Research Site 54
Vista, California · Recruiting
Clincial Research Site 47
Deerfield Beach, Florida · Active not recruiting
Clincial Research Site 38
Hollywood, Florida · Not yet recruiting
Clincial Research Site 40
Jacksonville, Florida · Recruiting
Clincial Research Site 19
Miami, Florida · Recruiting
Clincial Research Site 26
Miami, Florida · Recruiting
Clincial Research Site 13
Pembrook Pines, Florida · Recruiting
Clincial Research Site 51
Tamarac, Florida · Withdrawn
Clincial Research Site 22
Chicago, Illinois · Not yet recruiting
Clincial Research Site 34
Chicago, Illinois · Recruiting
Clincial Research Site 10
O'Fallon, Illinois · Recruiting
Clincial Research Site 49
Springfield, Illinois · Recruiting
Clincial Research Site 04
Bossier City, Louisiana · Recruiting
Clincial Research Site 01
Lafayette, Louisiana · Recruiting
Clincial Research Site 07
D'Iberville, Mississippi · Recruiting
Clincial Research Site 02
McComb, Mississippi · Recruiting
Clincial Research Site 30
New York, New York · Recruiting
Clincial Research Site 37
Syosset, New York · Recruiting
Clincial Research Site 55
Winston-Salem, North Carolina · Active not recruiting
Clincial Research Site 45
Grove City, Ohio · Withdrawn
Clincial Research Site 23
Mentor, Ohio · Withdrawn
Clincial Research Site 28
Tulsa, Oklahoma · Recruiting
Clincial Research Site 36
Philadelphia, Pennsylvania · Recruiting
Clincial Research Site 24
Fort Worth, Texas · Recruiting
Clincial Research Site 32
Houston, Texas · Recruiting
Clincial Research Site 46
San Antonio, Texas · Not yet recruiting
Clincial Research Site 18
Suffolk, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.